Sponsored by 
Sponsored by
The SCRS Eagle Award celebrates great partnerships between sites and the CROs and pharmaceutical Sponsors they work with every day. The site-industry relationship is a foundational part of clinical research success, informing industry innovation and progress.
But most importantly, it is this partnership between organizations that delivers the experience and insights for the most important member of our team, the patient.
For more than a decade, The Eagle Award has recognized outstanding leadership, professionalism, integrity, passion and dedication to advancing the clinical research profession through strong site partnerships. Eagle Award recipients are nominated based on criteria such as:
To Our Site Partners,
To be recognized as your sponsor of choice for the 2022 Global SCRS Eagle Award is an honor. We are immensely humbled and grateful for your partnership and collaboration.
This year has presented unique challenges and opportunities, yet we continue to be heartened by your unwavering commitment and dedication to delivering innovative treatments to patients. We are inspired by your passion, integrity and tireless dedication to the patients and communities you serve.
On behalf of everyone at our company, thank you for your vote and recognition. More importantly, thank you for the noble work you do every day in pursuit of better health outcomes around the world.
Andy Lee
Senior Vice President and Head of Global Clinical Trial Operations
Merck
Dear Site Colleagues,
For the second consecutive year, you, our site colleagues, have selected us – PPD, part of Thermo Fisher Scientific – as the 2022 Eagle Award winner for “Best CRO,” and words cannot begin to express how thankful we are for your collaboration, expertise and support over the years.
This prestigious industry award reflects our shared commitment to patients. Conducting clinical trials is complex and not without challenges. But together, we have the opportunity every day to make a positive impact on clinical research and help advance new therapies for patients in need.
Through forward-thinking approaches and an unwavering dedication to patients, together we have ensured the continuation of clinical trials despite global health constraints. We remain committed to working alongside you in the future, as we navigate whatever challenges may come our way, so we can continue to provide the highest level of service to patients, allowing us to enable our customers to make the world healthier.
We are dedicated to learning from you, our site partners, by listening to you through an open and candid dialogue so that we can continue to earn your trust and partnership. We acknowledge that our work together is ever-evolving, and we are committed to easing the burden of trial participation for sites and for patients, with the goal of creating the best participation experience possible.
Thank you to the Society for Clinical Research Sites (SCRS) for the opportunity to be considered for this award for yet another year. As the organization celebrates its 10th anniversary, we congratulate SCRS on its many achievements and its commitment to supporting the global site community.
If you are affiliated with a site and would like to contact our sites and patients center of excellence team, please email us at globalinvestigator.servicessm@ppd.com with the subject title, “Sites and Patients.”
On behalf of our entire team, thank you – and we look forward to what lies ahead, together.
Rodrigo Garcia, MD, MS
Vice President, Sites and Patients Center of Excellence
Clinical Research
PPD, part of Thermo Fisher Scientific
